These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22731843)

  • 1. Postpartum monitoring of retained placenta.Two cases of abnormally adherent placenta.
    Torrenga B; Huirne JA; Bolte AC; van Waesberghe JH; de Vries JI
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):472-5. PubMed ID: 22731843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservative management of abnormally invasive placenta: four case reports.
    Ramoni A; Strobl EM; Tiechl J; Ritter M; Marth C
    Acta Obstet Gynecol Scand; 2013 Apr; 92(4):468-71. PubMed ID: 23330969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of choriocarcinoma from postpartum placental remnants staying for extended times in the uterus.
    Hovav Y; Almagor M
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):720. PubMed ID: 24588544
    [No Abstract]   [Full Text] [Related]  

  • 4. [Conservative treatment of placenta accreta].
    Courbière B; Bretelle F; Porcu G; Gamerre M; Blanc B
    J Gynecol Obstet Biol Reprod (Paris); 2003 Oct; 32(6):549-54. PubMed ID: 14593301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The morbidly adherent placenta: diagnosis and management options.
    Hayes E; Ayida G; Crocker A
    Curr Opin Obstet Gynecol; 2011 Dec; 23(6):448-53. PubMed ID: 22002113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conservative management of morbidly adherant placenta - a case report and review of literature.
    Khan M; Sachdeva P; Arora R; Bhasin S
    Placenta; 2013 Oct; 34(10):963-6. PubMed ID: 23937959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservative management of abnormally invasive placentation.
    Timmermans S; van Hof AC; Duvekot JJ
    Obstet Gynecol Surv; 2007 Aug; 62(8):529-39. PubMed ID: 17634154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of placenta accreta.
    Sentilhes L; Goffinet F; Kayem G
    Acta Obstet Gynecol Scand; 2013 Oct; 92(10):1125-34. PubMed ID: 23869630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonremoval of an abnormally invasive placenta at cesarean section with postoperative uterine artery embolization.
    Chung MY; Cheng YK; Yu SC; Sahota DS; Leung TY
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1250-5. PubMed ID: 23937444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of placenta accreta].
    Kayem G; Grangé G; Goffinet F
    Gynecol Obstet Fertil; 2007 Mar; 35(3):186-92. PubMed ID: 17317266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human placental lactogen and color Doppler in predicting expulsion of retained adherent placenta: a new clinical observation.
    Zepiridis L; Zafrakas M; Theodoridis TD; Assimakopoulos E; Tzevelekis P; Athanatos D; Bontis JN; Tarlatzis BC
    Arch Gynecol Obstet; 2009 Dec; 280(6):1041-4. PubMed ID: 19333613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy and safety of uterine artery chemoembolization in abnormal placental implantation complicated with postpartum hemorrhage].
    Chen YT; Xu LF; Sun HL; Li HQ; Hu RM; Tan QY
    Zhonghua Fu Chan Ke Za Zhi; 2010 Apr; 45(4):273-7. PubMed ID: 20646539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of Placenta Percreta through a combinatorial treatment involving a Bakri Balloon and Methotrexate--a case report.
    Akdemir N; Cevrioğlu AS; Özden S; Gündüz Y; Ilhan G
    Ginekol Pol; 2015 Aug; 86(8):631-4. PubMed ID: 26492714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of pelvic embolization in the management of severe postpartum hemorrhage due to placenta accreta, increta or percreta.
    Soyer P; Morel O; Fargeaudou Y; Sirol M; Staub F; Boudiaf M; Dahan H; Mebazaa A; Barranger E; le Dref O
    Eur J Radiol; 2011 Dec; 80(3):729-35. PubMed ID: 20708361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conservative treatment of placenta increta with methotrexate.
    Crespo R; Lapresta M; Madani B
    Int J Gynaecol Obstet; 2005 Nov; 91(2):162-3. PubMed ID: 16126207
    [No Abstract]   [Full Text] [Related]  

  • 16. Serial magnetic resonance imaging of placenta percreta with bladder involvement during pregnancy and postpartum: a case report.
    Ueda Y; Kondoh E; Kakui K; Hamanishi J; Ueda M; Nishikawa A; Tatsumi K; Konishi I
    J Obstet Gynaecol Res; 2013 Jan; 39(1):359-63. PubMed ID: 22672446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservative management of placenta increta: case report and literature review.
    Yarandi F; Eftekhar Z; Shojaei H; Rahimi-Sharbaf F; Baradaran F
    Acta Med Iran; 2011; 49(6):396-8. PubMed ID: 21874645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial placenta increta and methotrexate therapy: three case reports.
    Pinho S; Sarzedas S; Pedroso S; Santos A; Rebordão M; Avillez T; Casal E; Hermida M
    Clin Exp Obstet Gynecol; 2008; 35(3):221-4. PubMed ID: 18754299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conservative management of abnormally invasive placenta after vaginal delivery.
    Kim TH; Lee HH
    Acta Obstet Gynecol Scand; 2014 Jan; 93(1):123-4. PubMed ID: 24116933
    [No Abstract]   [Full Text] [Related]  

  • 20. Magnetic resonance imagining (MRI) and serial beta-human chorionic gonadotrophin (beta-hCG) follow up for placenta percreta.
    El-Bialy G; Kassab A; Armstrong M
    Arch Gynecol Obstet; 2007 Oct; 276(4):371-3. PubMed ID: 17356825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.